Mar 1, 2026 Log in

News

【Kangpu Biotech Inc.】2026 Q1 EPS -0.07 NTD

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 8:26 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Kangpu Biotech Inc.
announced its Q1 2026 financial results, reporting an EPS of -0.07 NTD, with zero revenue and a net loss of 108 million NTD.
This indicates a loss-making quarter for the biotechnology company.

Kangpu Biotech Inc. announced its Q1 2026 financial results, reporting an EPS of -0.07 NTD, with zero revenue and a net loss of 108 million NTD. This indicates a loss-making quarter for the biotechnology company.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: Mar 1, 2026

Company Code: 6919 Company Name: Kangpu Biotech Inc. Industry: Biotechnology and Medical Year/Quarter: 2026 Q1 Basic Earnings Per Share: -0.07 NTD Operating Revenue: 0 NTD Net Profit After Tax: -108 million NTD

Keywords: Financial Report, Biotechnology and Medical, EPS

FACT BOX

Source: PR Times
Category: News
Products / services: Biotechnology products/services

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　May 1, 2026 8:00 AM
AI structured & analyzed　May 1, 2026 8:56 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6919-2026Q1

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“【Kangpu Biotech Inc.】2026 Q1 EPS -0.07 NTD”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.washinmura.jp/ai/%E5%BA%B7%E9%9C%88%E7%94%9F%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-05-01-kangpao-biotech-q1-eps

AI CRAWLER ACTIVITY

as of Jul 4, 2026

AI crawler visits to this article (cumulative)21 bots

Site-wide cumulative

ClaudeBot

bot_visits_summary

5025k

last Jul 4, 2026

GPTBot

bot_visits_summary

3387k

last Jul 4, 2026

Bingbot

bot_visits_summary

2071k

last Jul 4, 2026

Google AI

bot_visits_summary

1807k

last Jul 4, 2026

Googlebot

bot_visits_summary

1324k

last Jul 4, 2026

Applebot

bot_visits_summary

1146k

last Jul 4, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 康霈生技股份有限公司 Back to newsroom (13)

Copied